Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 24.69% is 163% above its 5-year average of 9.38%, near the high end of its 5-year range (2.83%–24.69%).
As of the fiscal period ended Tuesday, June 30, 2026. 129.95% above its 12-month average of 10.74%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 24.69%.
DEBT TO ASSETS RATIO
24.69%
DEBT TO ASSETS RATIO AVG TTM
10.74%
DEBT TO ASSETS RATIO AVG 3Y
9.75%
DEBT TO ASSETS RATIO AVG 5Y
9.38%
DEBT TO ASSETS RATIO AVG 10Y
17.32%
DEBT TO ASSETS RATIO AVG 15Y
28.47%
DEBT TO ASSETS RATIO AVG 20Y
22.78%
CURRENT VS TTM AVG
+129.95%
CURRENT VS 3Y AVG
+153.18%
CURRENT VS 5Y AVG
+163.34%
CURRENT VS 10Y AVG
+42.53%
CURRENT VS 15Y AVG
-13.29%
CURRENT VS 20Y AVG
+8.39%
SECTOR MEDIAN · HEALTHCARE
0.13%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
+18893.24%
vs the sector median at left
Capricor Therapeutics, Inc.
Market Cap
$447.43M
Debt to Assets Ratio
24.69%
TTM Avg
10.74%
3Y Avg
9.75%
5Y Avg
9.38%
Market Cap
$450.64M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$453.70M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$428.16M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$416.68M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$478.54M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Capricor Therapeutics, Inc. (CAPR) | $447.43M | 24.69% | 10.74% | 9.75% | 9.38% |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | 0.01% | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | 0.00% | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | 0.07% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $468.31M | 0.66% | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $471.57M | 0.37% | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $416.68M | 0.10% | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | 0.03% | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $415.93M | 0.19% | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $481.33M | 0.01% | N/A | N/A | N/A |
Debt/Assets
24.7%
Debt/Equity
0.37
Current Ratio
7.35
Interest Coverage
-35.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 24.69% |
| 2026-03-31 | 6.47% |
| 2025-12-31 | 5.04% |
| 2025-09-30 | 14.17% |
| 2025-06-30 | 3.31% |
| 2025-03-31 | 3.01% |
| 2024-12-31 | 2.83% |
| 2024-09-30 | 5.41% |
| 2024-06-30 | 13.62% |
| 2024-03-31 | 10.92% |
| 2023-12-31 | 9.56% |
| 2023-09-30 | 15.58% |
| 2023-06-30 | 12.17% |
| 2023-03-31 | 10.71% |
| 2022-12-31 | 11.85% |
| 2022-09-30 | 11.42% |
| 2022-06-30 | 10.53% |
| 2022-03-31 | 9.52% |
| 2021-12-31 | 15.11% |
| 2021-09-30 | 7.83% |
| 2021-06-30 | 8.46% |
| 2021-03-31 | 8.48% |
| 2020-12-31 | 10.67% |
| 2020-09-30 | 10.21% |
| 2020-06-30 | 9.95% |
| 2020-03-31 | 23.62% |
| 2019-12-31 | 30.38% |
| 2019-09-30 | 42.70% |
| 2019-06-30 | 46.21% |
| 2019-03-31 | 39.18% |
| 2018-12-31 | 36.51% |
| 2018-09-30 | 27.60% |
| 2018-06-30 | 23.57% |
| 2018-03-31 | 21.94% |
| 2017-12-31 | 20.75% |
| 2017-09-30 | 89.63% |
| 2017-06-30 | 99.56% |
| 2017-03-31 | 98.85% |
| 2016-12-31 | 74.18% |
| 2016-09-30 | 59.68% |
| 2016-06-30 | 87.50% |
| 2016-03-31 | 59.79% |
| 2015-12-31 | 56.98% |
| 2015-09-30 | 46.05% |
| 2015-06-30 | 38.65% |
| 2015-03-31 | 33.33% |
| 2014-12-31 | 67.16% |
| 2014-09-30 | 56.23% |
| 2014-06-30 | 46.87% |
| 2014-03-31 | 24.80% |
| 2013-12-31 | 71.54% |
| 2013-09-30 | 285.75% |
| 2013-06-30 | 87.68% |
| 2013-03-31 | 45.98% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2006-09-30 | 41538.67% |
| 2006-06-30 | 15124.71% |
| 2006-03-31 | 18148.79% |
| 2005-12-31 | 24709.61% |
| 2005-09-30 | 2195.61% |
| 2005-06-30 | 104621.67% |
| 2005-03-31 | 2194.98% |
| 2004-12-31 | 8188.66% |
| 2004-09-30 | 5445.83% |
| 2004-06-30 | 1324.77% |
| 2004-03-31 | 542.74% |
| 2003-12-31 | 3425.67% |
| 2003-09-30 | 175522.22% |
| 2003-06-30 | 82965.71% |
| 2003-03-31 | 39180.00% |
| 2002-12-31 | 30636.00% |
| 2002-09-30 | 3674.36% |
